Dear john,
 
Last week, the Biden administration released the initial group of medicines that will be subject to price negotiations with Medicare. They include:
 
·      Eliquis for preventing strokes and blood clots
·      Jardiance for diabetes and heart failure
·      Xarelto for preventing strokes and blood clots
·      Januvia for diabetes
·      Farxiga for diabetes, heart failure, and chronic kidney disease
·      Entresto for heart failure
·      Enbrel for arthritis and other autoimmune conditions
·      Imbruvica for blood cancers
·      Stelara for Crohn’s disease
·      Fiasp and NovoLog insulin products for diabetes

Made possible because of the Inflation Reduction Act, which I proudly voted for last year, this news is projected to reduce premiums and out-of-pocket costs for over 623,000 seniors in Texas and save the government $98.5 billion.
 
I’m thrilled about what this news will mean for El Pasoans. Affordable healthcare is near and dear to my heart and has long been a priority of mine as a public servant to our community. 
 
I remain committed to lowering prices and putting people over politics.